NutraTech's Other Investors

NutraTech raised a round of funding on , . Investors include Braveheart Investment Group.

Nutratech is a worldwide licensee for Caldroitin , which is a patent-pending calcium chondroitin sulfate that meets FDA's sodium guidelines for "sodium-free." The core target for glucosamine chondroit…

Articles about NutraTech's Other Investors: